This is a Validated Antibody Database (VAD) review about mouse Mdc1, based on 5 published articles (read how Labome selects the articles), using Mdc1 antibody in all methods. It is aimed to help Labome visitors find the most suited Mdc1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Mdc1 synonym: 6820401C03; AA413496; Nfbd1; mKIAA0170; mediator of DNA damage checkpoint protein 1; mediation of DNA damage checkpoint 1
Knockout validation
EMD Millipore mouse monoclonal (P2B11) |
| EMD Millipore Mdc1 antibody (Millipore, 05-1572) was used in western blot knockout validation on human samples at 1:1000 (fig 1g) and in immunocytochemistry on human samples at 1:1000 (fig 1f). Nat Commun (2018) ncbi |
Novus Biologicals
rabbit polyclonal |
| Novus Biologicals Mdc1 antibody (Novus, NB100-395) was used in immunohistochemistry on human samples (fig 5) and in western blot on human samples (fig 6). PLoS ONE (2015) ncbi |
rabbit polyclonal |
| Novus Biologicals Mdc1 antibody (Novus Biologicals, NB100-395) was used in immunocytochemistry on human samples (fig 5). Nucleic Acids Res (2016) ncbi |
EMD Millipore
mouse monoclonal (P2B11) |
| EMD Millipore Mdc1 antibody (Millipore, 05-1572) was used in western blot knockout validation on human samples at 1:1000 (fig 1g) and in immunocytochemistry on human samples at 1:1000 (fig 1f). Nat Commun (2018) ncbi |
mouse monoclonal (P2B11) |
| EMD Millipore Mdc1 antibody (Millipore, P2B11) was used in immunocytochemistry on mouse samples (fig 2d). Genes Dev (2017) ncbi |
mouse monoclonal (P2B11) |
| EMD Millipore Mdc1 antibody (Millipore, 05-1572) was used in immunocytochemistry on human samples at 1:500 (fig s1). Mol Biol Cell (2015) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments